Self-guided Psychosocial Intervention for Facial Palsy
Primary Purpose
Facial Palsy
Status
Completed
Phase
Not Applicable
Locations
United Kingdom
Study Type
Interventional
Intervention
Information and Therapy Guides
Sponsored by
About this trial
This is an interventional treatment trial for Facial Palsy
Eligibility Criteria
Inclusion Criteria:
Participant with Facial Palsy:
- Participant is willing and able to give informed consent for participation in the study.
- Aged 18 years or above.
- Current diagnosis of facial palsy, of any severity or aetiology.
- Participants experience one or more psychosocial difficulties related to facial palsy 'all the time' or 'a lot of the time', as assessed by a screening questionnaire
Participant who is a friend, family member or partner of someone with facial palsy:
- Participant is willing and able to give informed consent for participation in the study.
- Aged 18 years or above.
- Is a friend, family member or partner of an adult with facial palsy, of any severity or aetiology.
- Participants experience psychosocial difficulties related to supporting someone with facial palsy, as assessed by participant responding 'all the time' or 'a lot of the time' to one or more questions on a screening questionnaire
Exclusion Criteria:
Participant with Facial Palsy:
- The participant is not in within the target age range (e.g. under the age of 18 years).
- They are not an individual with a current diagnosis of facial palsy.
- They do not speak enough English to understand the questionnaires or ITGs.
- They do not meet eligibility on the screening questionnaire (i.e. they 'never' or 'only occasionally' experience psychosocial difficulties associated with facial palsy (see section 7.2 Screening and Eligibility Assessment).
Participant who is a friend, family member or partner of someone with facial palsy:
- The participant is not in within the target age range (e.g. under the age of 18 years).
- They are not a friend, family member or partner of an adult with a current diagnosis of facial palsy.
- They do not speak enough English to understand the questionnaires or ITG.
- They do not meet eligibility on the screening questionnaire (i.e. they 'never' or 'only occasionally' experience psychosocial difficulties associated with supporting someone with facial palsy
Sites / Locations
- John Radcliffe Hospital
Arms of the Study
Arm 1
Arm Type
Experimental
Arm Label
Facial Palsy - Trial of ITG
Arm Description
In this arm of the trial individuals with facial palsy will trial the use of information and therapy guides over a 4-6 week period. They will complete measures at the start and end of this period.
Outcomes
Primary Outcome Measures
FACE-Q Psychological Function
This 10-item scale measures psychological wellbeing using a series of positively worded statements, with participants invited to rate how much they agree/disagree with each statement. There is a minimum score of 10 and a maximum score of 40. Scores are Rasch transformed to a 0-100 scale. A high score indicates greater psychological wellbeing.
As some participants were eligible to trial multiple guides, some participants contributed multiple data points.
FACE-Q Psychological Function
This 10-item scale measures psychological wellbeing using a series of positively worded statements, with participants invited to rate how much they agree/disagree with each statement. There is a minimum score of 10 and a maximum score of 40. Scores are Rasch transformed to a 0-100 scale. A high score indicates greater psychological wellbeing.
As some participants were eligible to trial multiple guides, some participants contributed multiple data points.
FACE-Q Social Function
In this scale there are 8 statements pertaining to measuring social functioning. Scores on this scale range from 8 to 32, with scores Rasch transformed to a 0-100 scale. Higher scores indicate better social function.
As some participants were eligible to trial multiple guides, some participants contributed multiple data points.
FACE-Q Social Function
In this scale there are 8 statements pertaining to measuring social functioning. Scores on this scale range from 8 to 32, with scores Rasch transformed to a 0-100 scale. Higher scores indicate better social function.
As some participants were eligible to trial multiple guides, some participants contributed multiple data points.
Facial Disability Index (Social Function)
A 5-item self-report measure of social function in people with facial palsy. The scale is scored out of 100 (100 = high function).
As some participants were eligible to trial multiple guides, some participants contributed multiple data points.
Facial Disability Index (Social Function)
A 5-item self-report measure of social function in people with facial palsy. The scale is scored out of 100 (100 = high function).
As some participants were eligible to trial multiple guides, some participants contributed multiple data points.
FACE-Q Appearance-Related Psychosocial Distress
An eight-item scale assessing an individual's concerns regarding their facial appearance on a scale of 8-32, which is then Rasch transformed to a 0-100 scale. The higher the score, the greater the patient's dissatisfaction with their appearance.
As some participants were eligible to trial multiple guides, some participants contributed multiple data points.
FACE-Q Appearance-Related Psychosocial Distress
An eight-item scale assessing an individual's concerns regarding their facial appearance on a scale of 8-32, which is then Rasch transformed to a 0-100 scale. The higher the score, the greater the patient's dissatisfaction with their appearance.
As some participants were eligible to trial multiple guides, some participants contributed multiple data points.
Hospital Anxiety and Depression Scale
A 14-item scale with two seven-item subscales looking at anxiety and depression. A score equal-to-or-lower-than 7 on a subscale falls below the clinical cut-off, a score of 8-10 indicates probably clinically significant anxiety or depression, while a score of 11 or more indicates clinically significant anxiety or depression. Scores range from 0-52, with a higher score indicating higher severity.
As some participants with facial palsy were eligible to trial multiple guides, some participants with facial palsy contributed multiple data points.
Hospital Anxiety and Depression Scale
A 14-item scale with two seven-item subscales looking at anxiety and depression. A score equal-to-or-lower-than 7 on a subscale falls below the clinical cut-off, a score of 8-10 indicates probably clinically significant anxiety or depression, while a score of 11 or more indicates clinically significant anxiety or depression. Scores range from 0-52, with a higher score indicating higher severity.
As some participants with facial palsy were eligible to trial multiple guides, some participants with facial palsy contributed multiple data points.
Secondary Outcome Measures
Adult Carer Quality of Life Questionnaire
40 item questionnaire assessing carer quality of life. Possible scores range from 0-120, with higher scores indicating higher quality of life
Adult Carer Quality of Life Questionnaire
40 item questionnaire assessing carer quality of life. Possible scores range from 0-120, with higher scores indicating higher quality of life
Full Information
NCT ID
NCT03943953
First Posted
May 8, 2019
Last Updated
August 1, 2022
Sponsor
Oxford University Hospitals NHS Trust
1. Study Identification
Unique Protocol Identification Number
NCT03943953
Brief Title
Self-guided Psychosocial Intervention for Facial Palsy
Official Title
A Pilot Study Evaluating the Effectiveness of Information and Therapy Guides for Improving the Psychosocial Wellbeing of People With Facial Palsy.
Study Type
Interventional
2. Study Status
Record Verification Date
August 2022
Overall Recruitment Status
Completed
Study Start Date
August 15, 2019 (Actual)
Primary Completion Date
May 5, 2021 (Actual)
Study Completion Date
May 5, 2021 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Oxford University Hospitals NHS Trust
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No
5. Study Description
Brief Summary
Facial palsy affects between 23 to 35 people per 100,000. As well as affecting an individual's appearance, it also can lead to difficulties with: eating, drinking, speaking, eyelid closure, pain and taste.
Facial palsy has been shown to have a significant impact on an individual's psychological wellbeing, including issues with anxiety, depression and low self-esteem. These elevated levels of distress have been thought to be partly due to the impact that facial palsy has on the face's ability to express emotions, which is a crucial aspect of face-to-face communication.
Although not researched yet in a facial palsy population, one type of psychological intervention that has been found to be effective at improving the psychosocial wellbeing of people with visible differences has been psychological self-help. With this in mind, the investigators have developed seven self-guided information and therapy guides (ITGs), for people with facial palsy and/or their friends or relatives. The investigators have written these guides by drawing on interventions with a strong evidence-base in other populations, such as cognitive behavioural therapy, social skills training and acceptance and commitment therapy:
Facial palsy: Coping with the early stages.
Facial palsy: Coping with comments, questions and staring.
Facial palsy: Communicating with confidence.
Facial palsy: Managing anxiety.
Facial palsy: Managing your mood.
Facial palsy: Building your self-esteem.
Facial palsy: Advice for friends, family and partners.
The investigators aim to evaluate the effectiveness, usability and acceptability of these guides to people with facial palsy and/or their friends, family and partners, by piloting their use over a 4-6 week period. Assessment of psychosocial wellbeing will be carried out before and after the 4-6 week period, while participants will be invited to provide usability and acceptability feedback on the guides after the 4-6 week period.
Detailed Description
Given that this study represents an initial pilot of the use of self-guided information and therapy guides for people with facial palsy (and/or their friends and relatives), all eligible participants will receive the intervention (i.e. there will be no control group). As a result, this study will have a repeated-measures design.
Eligible participants will be recruited by one of two means:
Face-to-face of recruitment of OUH NHS patients during clinics at the Oxford Facial Palsy Service
Recruitment of people with facial palsy, not under the care of the Oxford Facial Palsy Service, through relevant web and social media pages (e.g. the Facial Palsy UK Facebook page)
Potential participants who have expressed an interest in the study will be provided with an information sheet, and be invited to provide written consent. Participants recruited through the Oxford Facial Palsy Service will proved written consent via Survey Hero, either in clinic or remotely online at a later if they wish for longer time to consider their involvement in the study. Participants recruited through Facial Palsy UK/social media will provide written consent via Survey Hero.
Once participants have provided consent, they will be provided with an online screening questionnaire (in order to check for eligibility). Participants recruited in Oxford Facial Palsy Service clinics will complete the screening questionnaire on the researcher's laptop. Alternatively, if participants recruited in clinic wish to have more time to consider whether or not to participate, they will be able to complete online screening (and subsequent baseline assessments) remotely online. Participants recruited on social media will be emailed a link to the screening questionnaire.
Eligible participants will then be invited to complete baseline questionnaires:
People with facial palsy: Hospital Anxiety and Depression Scale; FACE-Q Satisfaction with appearance; FACE-Q Psychological function; FACE-Q Social function and Facial Disability Index. The Facial Disability Index will allow for control of improvement in facial palsy symptoms over time.
Friends, relatives and partners: Hospital Anxiety and Depression Scale and Adult Carer Quality of Life Questionnaire.
Like the screening questionnaires, written consent and baseline questionnaires will be completed online.
Eligible participants will then be administered the relevant self-guided information and therapy guide. For eligible carers/relatives this will be the guide entitled "Facial palsy: Advice for friends, family and partners". For eligible participants with facial palsy, this will be determined by their score on the screening questionnaire.
Participants will then utilise the guide over a period of four-to-six weeks. Half-way through the intervention period (after 2-3 weeks), they will receive an email reminding them to complete the guide and will be provided a web-link to complete a questionnaire, designed for the purpose of the current study, measuring the participants' ratings of acceptability and usability of the guides (participant satisfaction questionnaire).
At the end of the four-to-six week period, participants will be re-administered the baseline questionnaires, along with a questionnaire designed for the purpose of the current study measuring the participants' ratings of acceptability and usability of the guides (participant satisfaction questionnaire). Participants with facial palsy will also be re-administered the initial screening questionnaire. This will indicate whether the participant is eligible to complete a further guide. If this is the case, then their post-intervention questionnaires will serve as a new baseline and the participant will be invited to complete the new guide over a second four-to-six week period (followed by the same follow-up assessments as followed the first guide). This process will occur up to a maximum of six times (reflecting the potential for a participant to trial all six guides). If they do not wish to complete further guides then the participant will be thanked for their involvement in the study and their involvement will be registered as 'complete'.
Friends, relatives and partners of people with facial palsy will only be required to complete pre and post questionnaires if they are actively involved in the study due to completing the friend, relative or partner ITG. Likewise, individuals with facial palsy are not required to complete questionnaires if they are not actively involved in the study (i.e. not trialing and ITG), but their friend or relative is.
The investigators aim to trial the guides over a period of one year (May 2019 - May 2020). This will lead to the predicted sample size of 140 participants (120 with facial palsy, 20 per each of the 6 guides; 20 friends and family). This target is based on there being approximately 3000 people who have access to the Facial Palsy UK website. Given that approximately one-third of people with facial palsy experience a significant level of distress; the investigators hope that our guides would be relevant to, and accessible by, around 1000 people. 140 is therefore a conservative estimate of the number of participants that the investigators will be able to recruit.
Participants recruited from OUH NHS Foundation trust will be provided with an information sheet during their clinic appointment with the Oxford Facial Palsy Service. Written consent will be obtained in the clinic by a member of the research team.
Participants recruited from social media will be provided with an information sheet via email and will provide written consent online.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Facial Palsy
7. Study Design
Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Model Description
One single group will be trialling a new self-guided psychological intervention
Masking
None (Open Label)
Allocation
N/A
Enrollment
97 (Actual)
8. Arms, Groups, and Interventions
Arm Title
Facial Palsy - Trial of ITG
Arm Type
Experimental
Arm Description
In this arm of the trial individuals with facial palsy will trial the use of information and therapy guides over a 4-6 week period. They will complete measures at the start and end of this period.
Intervention Type
Behavioral
Intervention Name(s)
Information and Therapy Guides
Intervention Description
We have developed seven self-guided information and therapy guides (ITGs), for people with facial palsy and/or their friends or relatives. We have written these guides by drawing on interventions with a strong evidence-base in other populations, such as cognitive behavioural therapy, social skills training and acceptance and commitment therapy:
Facial palsy: Coping with the early stages.
Facial palsy: Coping with comments, questions and staring.
Facial palsy: Communicating with confidence.
Facial palsy: Managing anxiety.
Facial palsy: Managing your mood.
Facial palsy: Building your self-esteem.
Facial palsy: Advice for friends, family and partners.
Primary Outcome Measure Information:
Title
FACE-Q Psychological Function
Description
This 10-item scale measures psychological wellbeing using a series of positively worded statements, with participants invited to rate how much they agree/disagree with each statement. There is a minimum score of 10 and a maximum score of 40. Scores are Rasch transformed to a 0-100 scale. A high score indicates greater psychological wellbeing.
As some participants were eligible to trial multiple guides, some participants contributed multiple data points.
Time Frame
Time 1: Baseline
Title
FACE-Q Psychological Function
Description
This 10-item scale measures psychological wellbeing using a series of positively worded statements, with participants invited to rate how much they agree/disagree with each statement. There is a minimum score of 10 and a maximum score of 40. Scores are Rasch transformed to a 0-100 scale. A high score indicates greater psychological wellbeing.
As some participants were eligible to trial multiple guides, some participants contributed multiple data points.
Time Frame
Time 2: 4-6 week follow-up
Title
FACE-Q Social Function
Description
In this scale there are 8 statements pertaining to measuring social functioning. Scores on this scale range from 8 to 32, with scores Rasch transformed to a 0-100 scale. Higher scores indicate better social function.
As some participants were eligible to trial multiple guides, some participants contributed multiple data points.
Time Frame
Time 1: Baseline
Title
FACE-Q Social Function
Description
In this scale there are 8 statements pertaining to measuring social functioning. Scores on this scale range from 8 to 32, with scores Rasch transformed to a 0-100 scale. Higher scores indicate better social function.
As some participants were eligible to trial multiple guides, some participants contributed multiple data points.
Time Frame
Time 2: 4-6 week follow-up
Title
Facial Disability Index (Social Function)
Description
A 5-item self-report measure of social function in people with facial palsy. The scale is scored out of 100 (100 = high function).
As some participants were eligible to trial multiple guides, some participants contributed multiple data points.
Time Frame
Time 1: Baseline
Title
Facial Disability Index (Social Function)
Description
A 5-item self-report measure of social function in people with facial palsy. The scale is scored out of 100 (100 = high function).
As some participants were eligible to trial multiple guides, some participants contributed multiple data points.
Time Frame
Time 2: 4-6 week follow-up
Title
FACE-Q Appearance-Related Psychosocial Distress
Description
An eight-item scale assessing an individual's concerns regarding their facial appearance on a scale of 8-32, which is then Rasch transformed to a 0-100 scale. The higher the score, the greater the patient's dissatisfaction with their appearance.
As some participants were eligible to trial multiple guides, some participants contributed multiple data points.
Time Frame
Time 1: Baseline
Title
FACE-Q Appearance-Related Psychosocial Distress
Description
An eight-item scale assessing an individual's concerns regarding their facial appearance on a scale of 8-32, which is then Rasch transformed to a 0-100 scale. The higher the score, the greater the patient's dissatisfaction with their appearance.
As some participants were eligible to trial multiple guides, some participants contributed multiple data points.
Time Frame
Time 2: 4-6 week follow-up
Title
Hospital Anxiety and Depression Scale
Description
A 14-item scale with two seven-item subscales looking at anxiety and depression. A score equal-to-or-lower-than 7 on a subscale falls below the clinical cut-off, a score of 8-10 indicates probably clinically significant anxiety or depression, while a score of 11 or more indicates clinically significant anxiety or depression. Scores range from 0-52, with a higher score indicating higher severity.
As some participants with facial palsy were eligible to trial multiple guides, some participants with facial palsy contributed multiple data points.
Time Frame
Time 1: Baseline
Title
Hospital Anxiety and Depression Scale
Description
A 14-item scale with two seven-item subscales looking at anxiety and depression. A score equal-to-or-lower-than 7 on a subscale falls below the clinical cut-off, a score of 8-10 indicates probably clinically significant anxiety or depression, while a score of 11 or more indicates clinically significant anxiety or depression. Scores range from 0-52, with a higher score indicating higher severity.
As some participants with facial palsy were eligible to trial multiple guides, some participants with facial palsy contributed multiple data points.
Time Frame
Time 2: 4-6 week follow-up
Secondary Outcome Measure Information:
Title
Adult Carer Quality of Life Questionnaire
Description
40 item questionnaire assessing carer quality of life. Possible scores range from 0-120, with higher scores indicating higher quality of life
Time Frame
Time 1: Baseline
Title
Adult Carer Quality of Life Questionnaire
Description
40 item questionnaire assessing carer quality of life. Possible scores range from 0-120, with higher scores indicating higher quality of life
Time Frame
Time 2: 4-6 week follow-up
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Participant with Facial Palsy:
Participant is willing and able to give informed consent for participation in the study.
Aged 18 years or above.
Current diagnosis of facial palsy, of any severity or aetiology.
Participants experience one or more psychosocial difficulties related to facial palsy 'all the time' or 'a lot of the time', as assessed by a screening questionnaire
Participant who is a friend, family member or partner of someone with facial palsy:
Participant is willing and able to give informed consent for participation in the study.
Aged 18 years or above.
Is a friend, family member or partner of an adult with facial palsy, of any severity or aetiology.
Participants experience psychosocial difficulties related to supporting someone with facial palsy, as assessed by participant responding 'all the time' or 'a lot of the time' to one or more questions on a screening questionnaire
Exclusion Criteria:
Participant with Facial Palsy:
The participant is not in within the target age range (e.g. under the age of 18 years).
They are not an individual with a current diagnosis of facial palsy.
They do not speak enough English to understand the questionnaires or ITGs.
They do not meet eligibility on the screening questionnaire (i.e. they 'never' or 'only occasionally' experience psychosocial difficulties associated with facial palsy (see section 7.2 Screening and Eligibility Assessment).
Participant who is a friend, family member or partner of someone with facial palsy:
The participant is not in within the target age range (e.g. under the age of 18 years).
They are not a friend, family member or partner of an adult with a current diagnosis of facial palsy.
They do not speak enough English to understand the questionnaires or ITG.
They do not meet eligibility on the screening questionnaire (i.e. they 'never' or 'only occasionally' experience psychosocial difficulties associated with supporting someone with facial palsy
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Matthew Hotton
Organizational Affiliation
Oxford University Hospitals NHS Trust
Official's Role
Principal Investigator
Facility Information:
Facility Name
John Radcliffe Hospital
City
Oxford
State/Province
Oxon
ZIP/Postal Code
OX3 9DU
Country
United Kingdom
12. IPD Sharing Statement
Plan to Share IPD
No
IPD Sharing Plan Description
No plan to make data available
Citations:
PubMed Identifier
21720412
Citation
Fu L, Bundy C, Sadiq SA. Psychological distress in people with disfigurement from facial palsy. Eye (Lond). 2011 Oct;25(10):1322-6. doi: 10.1038/eye.2011.158. Epub 2011 Jul 1.
Results Reference
background
PubMed Identifier
15547436
Citation
Coulson SE, O'dwyer NJ, Adams RD, Croxson GR. Expression of emotion and quality of life after facial nerve paralysis. Otol Neurotol. 2004 Nov;25(6):1014-9. doi: 10.1097/00129492-200411000-00026.
Results Reference
background
PubMed Identifier
23962642
Citation
Muftin Z, Thompson AR. A systematic review of self-help for disfigurement: effectiveness, usability, and acceptability. Body Image. 2013 Sep;10(4):442-50. doi: 10.1016/j.bodyim.2013.07.005. Epub 2013 Aug 17.
Results Reference
background
PubMed Identifier
9120441
Citation
Martyn CN, Hughes RA. Epidemiology of peripheral neuropathy. J Neurol Neurosurg Psychiatry. 1997 Apr;62(4):310-8. doi: 10.1136/jnnp.62.4.310. No abstract available.
Results Reference
background
PubMed Identifier
26634395
Citation
Hultcrantz M. Rehabilitation of Bells' palsy from a multi-team perspective. Acta Otolaryngol. 2016;136(4):363-7. doi: 10.3109/00016489.2015.1116124. Epub 2015 Dec 4.
Results Reference
background
PubMed Identifier
6880820
Citation
Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand. 1983 Jun;67(6):361-70. doi: 10.1111/j.1600-0447.1983.tb09716.x.
Results Reference
background
PubMed Identifier
27222106
Citation
Klassen AF, Cano SJ, Alderman A, East C, Badia L, Baker SB, Robson S, Pusic AL. Self-Report Scales to Measure Expectations and Appearance-Related Psychosocial Distress in Patients Seeking Cosmetic Treatments. Aesthet Surg J. 2016 Oct;36(9):1068-78. doi: 10.1093/asj/sjw078. Epub 2016 May 24.
Results Reference
background
PubMed Identifier
8959998
Citation
VanSwearingen JM, Brach JS. The Facial Disability Index: reliability and validity of a disability assessment instrument for disorders of the facial neuromuscular system. Phys Ther. 1996 Dec;76(12):1288-98; discussion 1298-300. doi: 10.1093/ptj/76.12.1288.
Results Reference
background
PubMed Identifier
35623976
Citation
Hotton M, Johnson D, Kilcoyne S, Dalton L. Evaluating the effectiveness and acceptability of information and therapy guides for improving the psychosocial well-being of people with facial palsy. J Plast Reconstr Aesthet Surg. 2022 Sep;75(9):3356-3364. doi: 10.1016/j.bjps.2022.04.022. Epub 2022 Apr 25.
Results Reference
derived
Learn more about this trial
Self-guided Psychosocial Intervention for Facial Palsy
We'll reach out to this number within 24 hrs